Zhou X - Search Results

1

Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients.

Wu C, Hao H, Li L, Zhou X, Guo Z, Zhang L, Zhang X, Zhong W, Guo H, Bremner RM, Lin P. Wu C, et al. Among authors: zhou x. J Thorac Oncol. 2009 Jan;4(1):30-6. doi: 10.1097/JTO.0b013e3181914125. J Thorac Oncol. 2009. PMID: 19096303 Free article.

2

Inhibition of miR-23a increases the sensitivity of lung cancer stem cells to erlotinib through PTEN/PI3K/Akt pathway.

Han Z, Zhou X, Li S, Qin Y, Chen Y, Liu H. Han Z, et al. Among authors: zhou x. Oncol Rep. 2017 Nov;38(5):3064-3070. doi: 10.3892/or.2017.5938. Epub 2017 Sep 4. Oncol Rep. 2017. PMID: 28901474

3

Clinicopathological features and outcomes of rare lung adenocarcinoma metastasis to the thyroid gland: A single-center, 11-year experience.

Gao X, Cao Z, Diao X, Zhang J, Zhao K, Yang L, Qian Z, Zhou X, Guo C, Chen Y, Liu Z, Li S. Gao X, et al. Among authors: zhou x. Thorac Cancer. 2024 Nov 18. doi: 10.1111/1759-7714.15486. Online ahead of print. Thorac Cancer. 2024. PMID: 39558503 Free article.

4

A malignant glomus tumor in the upper trachea.

Huang C, Liu QF, Chen XM, Li L, Han ZJ, Zhou XY, Liu L, Li SQ. Huang C, et al. Ann Thorac Surg. 2015;99(5):1812-4. doi: 10.1016/j.athoracsur.2014.05.102. Ann Thorac Surg. 2015. PMID: 25952217

5

Down-regulation of microRNA-26b modulates non-small cell lung cancer cells chemoresistance and migration through the association of PTEN.

Liang N, Zhou X, Zhao M, Zhao D, Zhu Z, Li S, Yang H. Liang N, et al. Among authors: zhou x. Acta Biochim Biophys Sin (Shanghai). 2015 Jul;47(7):530-8. doi: 10.1093/abbs/gmv046. Epub 2015 Jun 11. Acta Biochim Biophys Sin (Shanghai). 2015. Retraction in: Acta Biochim Biophys Sin (Shanghai). 2021 Dec 8;53(12):1743. doi: 10.1093/abbs/gmaa171 PMID: 26068649 Free article. Retracted.

6

Immunophenotypic and prognostic analysis of PAX8 and TTF-1 expressions in neuroendocrine carcinomas of thymic origin: A comparative study with their pulmonary counterparts.

Bi Y, Deng Y, Li S, Zhou X, Chen Y, Ma D, Mao X, Guan Y, Chen J, Meng Y. Bi Y, et al. Among authors: zhou x. J Surg Oncol. 2016 Nov;114(6):697-702. doi: 10.1002/jso.24393. Epub 2016 Oct 20. J Surg Oncol. 2016. PMID: 27761900

7

Downregulation of a novel long noncoding RNA TRPM2-AS promotes apoptosis in non-small cell lung cancer.

Huang C, Qin Y, Liu H, Liang N, Chen Y, Ma D, Han Z, Xu X, Zhou X, He J, Li S. Huang C, et al. Among authors: zhou x. Tumour Biol. 2017 Feb;39(2):1010428317691191. doi: 10.1177/1010428317691191. Tumour Biol. 2017. PMID: 28231726 Free article.

8

Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway.

Ma D, Li S, Cui Y, Li L, Liu H, Chen Y, Zhou X. Ma D, et al. Among authors: zhou x. Oncol Lett. 2018 May;15(5):6211-6216. doi: 10.3892/ol.2018.8086. Epub 2018 Feb 20. Oncol Lett. 2018. Retraction in: Oncol Lett. 2021 Mar;21(3):219. doi: 10.3892/ol.2021.12480 PMID: 29616103 Free PMC article. Retracted.

9

Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.

Qin Y, Zhou X, Huang C, Li L, Liu H, Liang N, Chen Y, Ma D, Han Z, Xu X, He J, Li S. Qin Y, et al. Among authors: zhou x. Gene. 2018 Oct 30;675:278-284. doi: 10.1016/j.gene.2018.06.062. Epub 2018 Jun 20. Gene. 2018. PMID: 29935356

10

Nodal promotes the malignancy of non-small cell lung cancer (NSCLC) cells via activation of NF-κB/IL-6 signals.

Xu X, Zhou X, Gao C, Cao L, Zhang Y, Hu X, Cui Y. Xu X, et al. Among authors: zhou x. Biol Chem. 2019 May 27;400(6):777-785. doi: 10.1515/hsz-2018-0392. Biol Chem. 2019. PMID: 30699065

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53,035 results

Search Page

Filters